LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
Clinical trial NCT00005858 · COMPLETED
Trial details
- NCT number
- NCT00005858
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-04-01
- Primary completion
- 2003-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.